Renalytix expands US clinical footprint with three kidneyintelX.dkd integrations

GSK wins European Commission approval for Shingrix prefilled syringe

Abbott launches Libre Assist for in-the-moment food decisions

RedHill advances RHB-102 across GI indications

FDA grants priority review for Sanofi's Tzield in young children with stage 2 type 1 diabetes

Samsung Bioepis begins direct commercialisation of BYOOVIZ in Europe

Diamyd Medical agrees accelerated efficacy readout in ongoing Phase 3 type 1 diabetes trial

Clywedog Therapeutics activates all clinical centres and patient dosing in balomenib Phase 1b study

Qlife's Egoo Health platform selected for major AI-driven diabetes and MASLD project in China

ALR Technologies announces GluCurve Pet CGM relaunch in Canada

Gan & Lee Pharmaceuticals launches third phase 3 trial of once-monthly bofanglutide

Novo Nordisk reports strong phase 2 results for amycretin in type 2 diabetes

Innovent Biologics reports primary and all key secondary endpoints met in mazdutide Phase 3 trial

Galmed Pharmaceuticals reports topline results for combination of Aramchol, Stivarga and metformin

Adocia files patent for long-acting peptide platform AdoXLong and updates on BioChaperone studies